Showing results (41-50 of 161) with videos related to
Sort By:
Pageof 17
Molecular Cytogenetics|December 16, 2014
Cytogenetically normal uterine leiomyomas without MED12-mutations - a source to identify unknown mechanisms of the development of uterine smooth muscle tumorsCarsten Holzmann, Dominique Nadine Markowski, Dirk Koczan, et al.Proteomics|June 19, 2012
Five years later: the current status of the use of proteomics and transcriptomics in EMF researchDariusz Leszczynski, David de Pomerai, Dirk Koczan, et al.Biochemistry and Biophysics Reports|September 29, 2017
Increased osteoblast viability at alkaline pH in vitro provides a new perspective on bone regenerationAnne-Marie Galow, Alexander Rebl, Dirk Koczan, et al.BMC Bioinformatics|August 8, 2006
Robust computational reconstitution - a new method for the comparative analysis of gene expression in tissues and isolated cell fractionsMartin Hoffmann, Dirk Pohlers, Dirk Koczan, et al.International Journal of Urology : Official Journal of the Japanese Urological Association|May 3, 2013
Expression profiling of metastatic renal cell carcinoma using gene set enrichment analysisMatthias Maruschke, Oliver W Hakenberg, Dirk Koczan, et al.Arthritis Research & Therapy|June 28, 2007
Constitutive upregulation of the transforming growth factor-beta pathway in rheumatoid arthritis synovial fibroblastsDirk Pohlers, Andreas Beyer, Dirk Koczan, et al.Molecular Cytogenetics|October 16, 2015
A rare coincidence of different types of driver mutations among uterine leiomyomas (UL)Carsten Holzmann, Dominique Nadine Markowski, Sabine Bartnitzke, et al.European Journal of Nuclear Medicine and Molecular Imaging|March 13, 2009
Early effects of FOLFOX treatment of colorectal tumour in an animal model: assessment of changes in gene expression and FDG kineticsLudwig G Strauss, Johannes Hoffend, Dirk Koczan, et al.Arthritis Research & Therapy|May 6, 2008
Molecular discrimination of responders and nonresponders to anti-TNF alpha therapy in rheumatoid arthritis by etanerceptDirk Koczan, Susanne Drynda, Michael Hecker, et al.Arthritis Research & Therapy|December 19, 2003
Differential gene expression in pristane-induced arthritis susceptible DA versus resistant E3 ratsLena Wester, Dirk Koczan, Jens Holmberg, et al.Pageof 17